SpaceX closed a $250 billion acquisition of xAI in the first half of 2026, a transaction large enough to distort aggregate private equity exit data for the period. Strip the deal from industry tallies and sponsored exits fell roughly 40% year-over-year, continuing a sellside drought that began in late 2024. The xAI purchase—structured as an all-equity swap between entities controlled by Elon Musk—counted as a private market exit under most reporting conventions but provided no actual liquidity to third-party limited partners.

The timing matters. SpaceX priced its own initial public offering at $135 per share three weeks after the xAI transaction closed, raising $6.8 billion in what advisors called the largest aerospace debut in history. Shares traded as high as $134 on the first day, then reversed. As of today's close, SpaceX stock sits at $78, down 42% from the March peak and below the IPO price for the first time. The decline erased $22 billion in market capitalization and left retail buyers who chased the opening-day rally underwater by an average of 38%.

The xAI deal's headline figure—ten times the size of the next-largest private transaction in H1 2026—allowed sponsors to report a nominal rebound in exit volumes. In reality, the number of deals completed fell to 147 globally, the lowest half-year count since 2020. Median time-to-exit stretched to 6.4 years, up from 5.1 years a year earlier. Secondary volume collapsed 53% as continuation funds found no natural buyers. The gap between private marks and public comps widened to 18% across growth-stage software, the steepest discount in three years. Allocators who relied on topline exit numbers without parsing the xAI effect misjudged the liquidity environment by half.

Operators should watch for sponsor behavior around the September reporting cycle. Firms holding cross-fund positions in SpaceX now face mark-to-market writedowns against the $135 cost basis, pressuring Q3 returns. Private AI infrastructure companies that used xAI's private valuation as a reference point—there were at least eleven such fundraises in Q2—will need to reset expectations with incoming LPs. Meanwhile, the SpaceX IPO's underperformance has stalled three other planned aerospace offerings, each postponed without revised timing.

The xAI transaction was real. The liquidity it suggested was not.